These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7900331)

  • 1. [The omeprazole treatment of patients with diseases of the upper digestive tract].
    Degtiareva II; Zukheĭr Kh; Lodianaia EV; Palladina OL; Nevstruev VP; Piletskiĭ AM; Chervak IN
    Lik Sprava; 1994; (7-8):117-20. PubMed ID: 7900331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metoclopramide: interest in treatment of upper digestive burns (author's transl)].
    Halfon M
    Sem Hop; 1980 Jan 18-25; 56(3-4):193-4. PubMed ID: 6244656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Omeprazole].
    Ebert R
    Internist (Berl); 1992 Sep; 33(9):622-6. PubMed ID: 1399395
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of otsid in treating patients with chronic gastroduodenitis and duodenal peptic ulcer].
    Lobenko AA; Gozhenko AI; Vasil'ev VA
    Lik Sprava; 1997; (4):118-21. PubMed ID: 9471350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
    Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
    Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic anemia associated with the use of omeprazole.
    Marks DR; Joy JV; Bonheim NA
    Am J Gastroenterol; 1991 Feb; 86(2):217-8. PubMed ID: 1992636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
    Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
    N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of peptic ulcer: role of Helicobacter pylori gastritis and its course during antibiotic and/or antisecretory treatment].
    Solcia E; Villani L; Luinetti O; Fiocca R
    Minerva Gastroenterol Dietol; 1992; 38(2):81-93. PubMed ID: 1343564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Esophagitis, gastritis and duodenitis provoked by cure of Helicobacter pylori infection].
    Shiotani A; Nishioka S
    Nihon Rinsho; 1999 Jan; 57(1):191-5. PubMed ID: 10036961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
    Labenz J; Gyenes E; Rühl GH; Börsch G
    Z Gastroenterol; 1992 Nov; 30(11):776-8. PubMed ID: 1471383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
    Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N
    Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication].
    Maeyama S; Yoshihara H; Kamada T; Kubota S; Kobayashi I; Tsuji S; Kawano S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():512-5. PubMed ID: 16363591
    [No Abstract]   [Full Text] [Related]  

  • 18. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
    Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omeprazole on serum gastrin levels: influence of age and sex.
    Koop H; Naumann-Koch C; Arnold R
    Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.